Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-case Performance

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 30, Issue 6, 2003, Pages 387-404

  Zhang, Liping ^a   Beal, Stuart L ^a   Sheiner, Lewis B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Data analysis; Forcing function; Modeling; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; COMPARTMENT MODEL; CONCENTRATION RESPONSE; DATA ANALYSIS; DOSE RESPONSE; FIRST ORDER CONDITIONAL ESTIMATION METHOD; INTERMETHOD COMPARISON; MEASUREMENT; PARAMETER; PERFORMANCE; POPULATION DISTRIBUTION; PREDICTION; PRIORITY JOURNAL; SEQUENTIAL ANALYSIS; SIMULATION; STANDARD;

COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; MODELS, BIOLOGICAL; PHARMACOKINETICS; PHARMACOLOGY; RESEARCH DESIGN; TIME FACTORS;

EID: 1242269757     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOPA.0000012998.04442.1f     Document Type: Article

References (16)

1. D. M. Foster. Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system. Adv. Exp. Med. Biol. 445:59-78 (1998).
2. J. Bennett and J. Wakefield. Errors-in-variables in joint population pharmacokinetic/pharmacodynamic modeling. Biometrics 57:803-812 (2001).
3. Y. Hashimoto and L. B. Sheiner. Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis. J. Pharmacokinet. Biopharm. 19:333-353 (1991).
4. J. Shi, N. L. Benowitz, C. P. Denaro, and L. B. Sheiner. Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects. Clin. Pharmacol. Ther. 53:6-14 (1993).
5. K. E. Fattinger, D. Verotta, H. C. Porchet, A. Munafo, J. Y. Le Cotonnec, and L. B. Sheiner. Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide. Am. J. Physiol. 271:E775-787. (1996).
6. J. R. Wade and M. O. Karlsson. In Population Approach Group Europe, Saintes, France, (1999).
7. L. Sheiner and J. Wakefield. Population modelling in drug development. Stat. Methods Med. Res. 8:183-193 (1999).
8. M. Davidian and D. Giltinan. Nonlinear Models for Repeated Measurement Data. Chapman & Hall, London (1995).
9. H. C. Kimko, S. S. Reele, N. H. Holford, and C. C. Peck. Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic model. Clin. Pharmacol. Ther. 68:568-577 (2000).
10. J. C. Wakefield, L. Aarons, and A. Racine-Poon. The Bayesian approach of population pharmacokinetic/pharmacodynamic modelling Springer-Verlag, (1998).
11. L. Zhang, R. Price, F. Aweeka, S. E. Bellibas, and L. B. Sheiner. Making the most of sparse clinical data by using a predictive-model-based analysis, illustrated with a stavudine pharmacokinetic study. Eur. J. Pharm. Sci. 12:377-385. (2001).
12. M. Gibaldi and D. Perrier. Pharmacokinetics. Marcel Dekker, New York (1982).
13. M. L. Stein. Large sample properties of simulations using Latin hypercube sampling. Technometrics 29:143-151 (1987).
14. A. B. Owen. Controlling correlations in Latin hypercube samples. J. Am. Stat. Assoc. 89:1517-1522 (1994).
15. S. L. Beal and L. B. Sheiner. NONMEM Users Guides. Globomax, Inc., Maryland. (1989-1998).
16. A. R. Gallant. Nonlinear Statistical Models. John Wiley & Sons, Inc., New York, p. 217 (1986).